跳至主要内容
临床试验/KCT0004211
KCT0004211撤回未知

Optimal dose for topical use of tranexamic acid after cardiovascular surgery

Korea University Anam Hospital0 个研究点目标入组 123 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
撤回
入组人数
123

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 80(Year)(—)
性别
All

入选标准

  • An adult who has been operated on for heart and aortic disease
  • -Men and women aged 19 and over
  • -Those who voluntarily agree to this study

排除标准

  • -In case of preoperative antifibrinolytics used
  • -In case who was diagnosed with preoperative blood clot disease
  • -In case of liver cirrhosis
  • -Patients with thrombotic thrombosis and such a history
  • -Patients who overreact to this drug and its constituent parts

研究者

相似试验